617
Participants
Start Date
October 25, 2018
Primary Completion Date
October 3, 2022
Study Completion Date
June 4, 2024
Pembrolizumab
IV infusion
Paclitaxel
IV infusion
Cisplatin
IV infusion
Carboplatin
IV infusion
Bevacizumab
IV infusion
Placebo to pembrolizumab
IV infusion
Koo Foundation Sun Yat-Sen Cancer Center ( Site 1636), Taipei
Taipei Veterans General Hospital ( Site 1631), Taipei
Kaohsiung Veterans General Hospital ( Site 1632), Kaohsiung City
Royal North Shore Hospital ( Site 1514), St Leonards
Monash Health-Monash Medical Centre ( Site 1519), Clayton
Mater Misericordiae Ltd Mater Cancer Care Centre ( Site 1521), South Brisbane
Flinders Medical Centre ( Site 1513), Bedford Park
St John of God Subiaco Hospital ( Site 1512), Subiaco
Mount Sinai Chelsea ( Site 1760), New York
Columbia University Medical Center ( Site 1800), New York
Hospital de Alta Complejidad de La Libertad Virgen de La Puerta ( Site 1152), Trujillo
Institut Paoli Calmettes ( Site 1182), Marseille
Instituto Nacional de Cancerologia. ( Site 1130), México
Hospital Nacional Guillermo Almenara Irigoyen ( Site 1158), Lima
Instituto de Oncologia y Radioterapia Clinica Ricardo Palma ( Site 1157), Lima
Instituto Nacional de Enfermedades Neoplasicas ( Site 1153), Lima
Hospital Nacional Arzobispo Loayza ( Site 1159), Lima
Hospital Nacional Maria Auxiliadora ( Site 1155), Lima
Onkologikoa - Instituto Oncologico de San Sebastian ( Site 1275), Doniostia - San Sebastian
Istituto Nazionale Tumori ( Site 1251), Milan
Istituto Europeo di Oncologia ( Site 1250), Milan
Universitatsklinikum Hamburg-Eppendorf ( Site 1212), Hamburg
Universitaetsklinikum Schleswig-Holstein Campus Kiel ( Site 1214), Kiel
Klinikum Oldenburg AoeR ( Site 1218), Oldenburg
MD Anderson Cancer Center Madrid ( Site 1273), Madrid
Hospital Quiron Madrid ( Site 1277), Pozuelo de Alarcón
MUSC Hollings Cancer Center ( Site 1819), Charleston
Gynoncological Practice Lueck. Schrader. Noeding ( Site 1224), Hanover
Georgia Cancer Center at Augusta University ( Site 1767), Augusta
Centro Estatal de Cancerologia de Chihuahua ( Site 1123), Chihuahua City
Centro di Riferimento Oncologico de Aviano Istituto Nazionale Tumori ( Site 1243), Aviano
Chang Gung Medical Foundation. Linkou ( Site 1633), Taoyuan District
H. Lee Moffitt Cancer Center and Research Institute ( Site 1754), Tampa
Medeniyet University Goztepe Egitim ve Arastırma Hast. Merdivenkoy ( Site 1458), Istanbul
Ege University Medical Faculty Tulay Aktas Oncology Hospital ( Site 1456), Izmir
Centre Eugene Marquis ( Site 1187), Rennes
West Cancer Center - East Campus ( Site 1763), Germantown
A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 1245), Bolgna
Universitaetsklinikum Duesseldorf ( Site 1220), Düsseldorf
China Medical University Hospital ( Site 1635), Taichung
Taichung Veterans General Hospital ( Site 1634), Taichung
Hospital Universitario Virgen Macarena ( Site 1274), Seville
Necmettin Erbakan Universitesi Meram Tip Fakultesi Hastanesi ( Site 1452), Konya
Keimyung University Dongsan Medical Center ( Site 1603), Daegu
OSU Wexner Medical Center ( Site 1817), Hilliard
Universitatsklinikum Essen AoR ( Site 1213), Essen
Barbara Ann Karmanos Cancer Institute ( Site 1785), Detroit
Henry Ford Health System ( Site 1810), Detroit
City Clinical Hosp.4 of DCC ( Site 1482), Dnipropetrovsk
Communal non profit enterprise Regional Clinical Oncology Center ( Site 1489), Kharkiv
Centre Jean Perrin ( Site 1181), Clermont-Ferrand
Washington University School of Medicine ( Site 1779), St Louis
MI Odessa Regional Oncological Centre ( Site 1493), Odesa
Centro de Urologia Avanzada del Noreste S.A. de C.V. ( Site 1125), San Pedro Garza García
Medical Centre LLC Oncolife ( Site 1485), Zaporizhzhya
University of Oklahoma- Stephenson Oklahoma Cancer Center ( Site 1784), Oklahoma City
Oklahoma Cancer Specialists and Research Institute, LLC ( Site 1768), Tulsa
Groupe Hospitalier Broca Cochin Hotel Dieu ( Site 1183), Paris
MI Precarpathian Clinical Oncology Center ( Site 1487), Ivano-Frankivsk
Texas Oncology-San Antonio Medical Center ( Site 8001), San Antonio
Istituto Nazionale Tumori IRCCS Fondazione Pascale ( Site 1242), Napoli
Rotkreuzklinikum Muenchen gGmbH. Studienzentrale Frauenklinik ( Site 1225), München
Arizona Oncology Associates, PC- HAL ( Site 8005), Phoenix
Faicic S de RL de CV ( Site 1133), Veracruz
Institut Curie - Centre Rene Huguenin ( Site 1185), Saint-Cloud
UC Irvine Health ( Site 1796), Orange
Universitaet Regensburg ( Site 1221), Regensburg
Medical Care and Research S.A. de C.V. ( Site 1135), Mérida
Seattle Cancer Care Alliance ( Site 1777), Seattle
Alaska Women's Cancer Care ( Site 1770), Anchorage
Instituto Nacional de Cancerologia E.S.E ( Site 1095), Bogota
FSBI National Medical Oncology Research Center n.a. N.N. Blokhina ( Site 1334), Moscow
Medical Rehabilitation Center ( Site 1337), Moscow
National Medical Research Center of Oncology n.a. N. N. Petrov ( Site 1348), Saint Petersburg
Municipal Clinical Oncology Center ( Site 1346), Saint Petersburg
Sociedad de Oncologia y Hematologia del Cesar Ltda. ( Site 1103), Valledupar
Oncomedica S.A. ( Site 1098), Montería
Republican Clinical Oncology Dispensary of Tatarstan MoH ( Site 1331), Kazan'
National Research Ogarev Mordovia State University ( Site 1347), Saransk
Republican Clinical Oncology Dispensary of Republic of Bashkortostan ( Site 1345), Ufa
Instituto Cancerologico de Narino Ltda ( Site 1097), Pasto
Novosibirsk Regional Clinical Oncology Dispensary ( Site 1358), Novosibirsk
Tomsk Scientific Research Institute of Oncology ( Site 1360), Tomsk
Hemato Oncologos S.A. ( Site 1100), Santiago de Cali
Oncocentro ( Site 1065), Viña del Mar
Rambam Medical Center ( Site 1364), Haifa
Instituto Clinico Oncologico del Sur ( Site 1062), Temuco
Rabin Medical Center ( Site 1365), Petah Tikva
Chaim Sheba Medical Center ( Site 1361), Ramat Gan
Sourasky Medical Center ( Site 1362), Tel Aviv
Fundacion Arturo Lopez Perez FALP ( Site 1061), Santiago
Sociedad Oncovida S.A. ( Site 1069), Santiago
Centro de Cancer Nuestra Senora de la Esperanza ( Site 1063), Santiago
Soroka Medical Center ( Site 1363), Beersheba
Shaare Zedek Medical Center ( Site 1366), Jerusalem
Hadassah Medical Center. Ein Kerem ( Site 1367), Jerusalem
Smilow Cancer Hospital at Yale New Haven ( Site 1809), New Haven
Cancer Institute of New Jersey at University Hospital ( Site 1762), Newark
Holy Name Medical Center ( Site 1776), Teaneck
Centro de Oncologia e Investigacion Buenos Aires COIBA ( Site 1006), Berazategui
Hospital Aleman ( Site 1005), Buenos Aires
Hospital de Oncologia Angel Roffo ( Site 1003), Buenos Aires
Instituto Medico Especializado Alexander Fleming ( Site 1009), Buenos Aires
Centro Oncologico Riojano Integral ( Site 1004), La Rioja
Centro Medico San Roque ( Site 1001), San Miguel de Tucumán
Tom Baker Cancer Centre ( Site 1728), Calgary
BC Cancer-Kelowna - Sindi Ahluwalia Hawkins Centre ( Site 1734), Kelowna
BC Cancer - Vancouver Center ( Site 1722), Vancouver
CancerCare Manitoba ( Site 1725), Winnipeg
Queen Elizabeth II Health Sciences Centre ( Site 1731), Halifax
Juravinski Cancer Centre ( Site 1735), Hamilton
London Regional Cancer Program - London HSC ( Site 1723), London
The Ottawa Hospital Cancer Centre ( Site 1736), Ottawa
Sunnybrook Research Institute ( Site 1733), Toronto
Princess Margaret Cancer Centre ( Site 1732), Toronto
CIUSSS du Saguenay-Lac-St-Jean ( Site 1729), Chicoutimi
CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont ( Site 1726), Montreal
Centre Hospitalier de l Universite de Montreal - CHUM ( Site 1721), Montreal
CHU de Quebec-Universite Laval-Hotel Dieu de Quebec ( Site 1724), Québec
CIUSSS de l Estrie - CHUS - Centre Hosp. Univ. Sherbrooke ( Site 1730), Sherbrooke
Biomelab S A S ( Site 1104), Barranquilla
Universitaetsklinikum Carl Gustav Carus ( Site 1211), Dresden
Policlinico Universitario -Agostino Gemelli ( Site 1241), Roma
The Jikei University Kashiwa Hospital ( Site 1701), Kashiwa
National Cancer Center Hospital East ( Site 1704), Kashiwa
Ehime University Hospital ( Site 1693), Tōon
Kurume University Hospital ( Site 1692), Kurume
National Hospital Organization Hokkaido Cancer Center ( Site 1700), Sapporo
Hyogo Cancer Center ( Site 1705), Akashi
Iwate Medical University Hospital ( Site 1695), Shiwa-gun
University of the Ryukyus Hospital ( Site 1706), Nakagami-gun
Saitama Medical University International Medical Center ( Site 1691), Hidaka
Shizuoka Cancer Center Hospital and Research Institute ( Site 1703), Sunto-gun
National Cancer Center Hospital ( Site 1702), Tokyo
The Jikei University Hospital ( Site 1697), Tokyo
The Cancer Institute Hospital of JFCR ( Site 1698), Tokyo
Keio University Hospital ( Site 1699), Tokyo
Consultorio de Medicina Especializada del Sector Privado ( Site 1129), Mexico City
CRYPTEX Investigacion Clinica S.A. de C.V. ( Site 1127), Mexico City
Centro Medico Monte Carmelo ( Site 1156), Arequipa
Seoul National University Hospital ( Site 1602), Seoul
Asan Medical Center ( Site 1601), Seoul
Samsung Medical Center ( Site 1604), Seoul
Hospital Germans Trias i Pujol. ICO de Badalona ( Site 1276), Badalona
Baskent Adana Dr Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 1457), Adana
Hacettepe University Medical Faculty ( Site 1459), Ankara
Baskent Universitesi Ankara Hastanesi ( Site 1451), Ankara
Akdeniz Universitesi Tip Fakultesi ( Site 1453), Antalya
National Cancer Institute of the MoH of Ukraine ( Site 1484), Kyiv
Merck Sharp & Dohme LLC
INDUSTRY